Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations

2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biologics Contract Development Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Source (Mammalian, Microbial, Others)
5.2.2. By Service (Cell Line Development, Process Development, Others)
5.2.3. By Indication (Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, Others)
5.2.4. By Region
5.2.5. By Company (2023)
5.3. Market Map
5.3.1. By Source
5.3.2. By Service
5.3.3. By Indication
5.3.4. By Region

6. Asia Pacific Biologics Contract Development Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Source
6.2.2. By Service
6.2.3. By Indication
6.2.4. By Country
6.3. Asia Pacific: Country Analysis
6.3.1. China Biologics Contract Development Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Source
6.3.1.2.2. By Service
6.3.1.2.3. By Indication
6.3.2. India Biologics Contract Development Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Source
6.3.2.2.2. By Service
6.3.2.2.3. By Indication
6.3.3. Australia Biologics Contract Development Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Source
6.3.3.2.2. By Service
6.3.3.2.3. By Indication
6.3.4. Japan Biologics Contract Development Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Source
6.3.4.2.2. By Service
6.3.4.2.3. By Indication
6.3.5. South Korea Biologics Contract Development Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Source
6.3.5.2.2. By Service
6.3.5.2.3. By Indication

7. Europe Biologics Contract Development Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Source
7.2.2. By Service
7.2.3. By Indication
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Biologics Contract Development Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Source
7.3.1.2.2. By Service
7.3.1.2.3. By Indication
7.3.2. Germany Biologics Contract Development Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Source
7.3.2.2.2. By Service
7.3.2.2.3. By Indication
7.3.3. Spain Biologics Contract Development Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Source
7.3.3.2.2. By Service
7.3.3.2.3. By Indication
7.3.4. Italy Biologics Contract Development Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Source
7.3.4.2.2. By Service
7.3.4.2.3. By Indication
7.3.5. United Kingdom Biologics Contract Development Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Source
7.3.5.2.2. By Service
7.3.5.2.3. By Indication

8. North America Biologics Contract Development Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Source
8.2.2. By Service
8.2.3. By Indication
8.2.4. By Country
8.3. North America: Country Analysis
8.3.1. United States Biologics Contract Development Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Source
8.3.1.2.2. By Service
8.3.1.2.3. By Indication
8.3.2. Mexico Biologics Contract Development Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Source
8.3.2.2.2. By Service
8.3.2.2.3. By Indication
8.3.3. Canada Biologics Contract Development Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Source
8.3.3.2.2. By Service
8.3.3.2.3. By Indication

9. South America Biologics Contract Development Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Source
9.2.2. By Service
9.2.3. By Indication
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Biologics Contract Development Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Source
9.3.1.2.2. By Service
9.3.1.2.3. By Indication
9.3.2. Argentina Biologics Contract Development Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Source
9.3.2.2.2. By Service
9.3.2.2.3. By Indication
9.3.3. Colombia Biologics Contract Development Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Source
9.3.3.2.2. By Service
9.3.3.2.3. By Indication
10. Middle East and Africa Biologics Contract Development Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Source
10.2.2. By Service
10.2.3. By Indication
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Biologics Contract Development Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Source
10.3.1.2.2. By Service
10.3.1.2.3. By Indication
10.3.2. Saudi Arabia Biologics Contract Development Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Source
10.3.2.2.2. By Service
10.3.2.2.3. By Indication
10.3.3. UAE Biologics Contract Development Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Source
10.3.3.2.2. By Service
10.3.3.2.3. By Indication
10.3.4. Egypt Biologics Contract Development Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Source
10.3.4.2.2. By Service
10.3.4.2.3. By Indication
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Product Launches (If Any)
12.3. Mergers & Acquisitions (If Any)

13. Global Biologics Contract Development Market: SWOT Analysis

14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product

15. Competitive Landscape
15.1. WuXi Biologics
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Abzena Ltd
15.3. Fujifilm Diosynth Biotechnologies
15.4. KBI Biopharma
15.5. AGC Biologics
15.6. Thermo Fisher Scientific Inc.
15.7. Curia Global, Inc.
15.8. Genscript
15.9. Bionova Scientific, Inc.
15.10. BioXcellence (Boehringer Ingelheim Biopharmaceuticals GmbH)

16. Strategic Recommendations

17. About Us & Disclaimer